Lower Bone Mass and Higher Bone Resorption in Pheochromocytoma: Importance of Sympathetic Activity on Human Bone

The effects of beta-2 adrenergic agonist and antagonist on human bone metabolism: A randomized controlled trial

(2015) A.G. Veldhuis-Vlug et al.   BONE

β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects

(2013) K. A. Toulis et al.   OSTEOPOROSIS INTERNATIONAL

The Skeleton and the Sympathetic Nervous System: It's about Time!

(2012) Katherine J. Motyl et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Relationship of Sympathetic Activity to Bone Microstructure, Turnover, and Plasma Osteopontin Levels in Women

(2012) Joshua N. Farr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone Resorption Is Increased in Pheochromocytoma Patients and Normalizes following Adrenalectomy

(2012) A. G. Veldhuis-Vlug et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual

(2011) Daisuke Kajimura et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Effect of Inhaled Glucocorticoids and β2 Agonists on Vertebral Fracture Risk in COPD Patients: The EOLO Study

(2010) S. Gonnelli et al.   CALCIFIED TISSUE INTERNATIONAL

Continuous Treatment with a Low-Dose β-Agonist Reduces Bone Mass by Increasing Bone Resorption Without Suppressing Bone Formation

(2010) Hisataka Kondo et al.   CALCIFIED TISSUE INTERNATIONAL